NasdaqCM - Nasdaq Real Time Price • USD
Heron Therapeutics, Inc. (HRTX)
As of 11:28 AM EDT. Market Open.
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.42M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FORBES WILLIAM P Officer | -- | Direct | -- | Apr 19, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 19, 2024 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Apr 19, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 3, 2024 |
| JOHNSON CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| RODRIGUEZ SUSAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| DISSANAIKE SHARMILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| MORGAN ADAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| CHRISTIAN WAAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| PERAZA LISA Officer | -- | Direct | -- | Jan 12, 2024 |
| FORBES WILLIAM P Officer | Purchase at price 1.09 per share. | Direct | 27,250 | Nov 17, 2023 |
| FORBES WILLIAM P Officer | Purchase at price 0.94 per share. | Direct | 46,995 | Nov 16, 2023 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | Purchase at price 0.92 per share. | Direct | 137,970 | Nov 16, 2023 |
| DUARTE IRA Chief Financial Officer | Purchase at price 0.89 per share. | Direct | 75,599 | Nov 16, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Oct 13, 2023 |
| MORGAN ADAM Director | Purchase at price 1.37 per share. | Indirect | 3,406,839 | Jul 21, 2023 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Jul 13, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Jul 13, 2023 |
| MANHARD KIMBERLY J Officer | -- | Direct | -- | Apr 13, 2023 |
| POYHONEN JOHN W President | -- | Direct | -- | Apr 13, 2023 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Apr 13, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Apr 13, 2023 |
| MORGAN ADAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 22, 2023 |
| QUART BARRY D Chief Executive Officer | -- | Direct | -- | Jan 13, 2023 |
| MANHARD KIMBERLY J Officer and Director | -- | Direct | -- | Jan 13, 2023 |
| POYHONEN JOHN W President | -- | Direct | -- | Jan 13, 2023 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Jan 13, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Jan 13, 2023 |
| DAVIS STEPHEN R Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
| JOHNSON CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
| WAAGE CHRISTIAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
| RODRIGUEZ SUSAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
| DISSANAIKE SHARMILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
| QUART BARRY D Chief Executive Officer | -- | Direct | -- | Oct 13, 2022 |
| MANHARD KIMBERLY J Officer and Director | -- | Direct | -- | Oct 13, 2022 |
| POYHONEN JOHN W President | -- | Direct | -- | Oct 13, 2022 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Oct 13, 2022 |
| PERAZA LISA Officer | -- | Direct | -- | Oct 13, 2022 |
| QUART BARRY D Chief Executive Officer | -- | Direct | -- | Jul 13, 2022 |
| MANHARD KIMBERLY J Officer and Director | -- | Direct | -- | Jul 13, 2022 |
| POYHONEN JOHN W President | -- | Direct | -- | Jul 13, 2022 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Jul 13, 2022 |
| PERAZA LISA Officer | -- | Direct | -- | Jul 13, 2022 |
| MANHARD KIMBERLY J Officer and Director | Sale at price 4.76 per share. | Direct | 7,154 | May 3, 2022 |
| QUART BARRY D Chief Executive Officer | -- | Direct | -- | Apr 13, 2022 |
| MANHARD KIMBERLY J Officer and Director | -- | Direct | -- | Apr 13, 2022 |
| POYHONEN JOHN W President | -- | Direct | -- | Apr 13, 2022 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Apr 13, 2022 |
| PERAZA LISA Officer | -- | Direct | -- | Apr 13, 2022 |
| QUART BARRY D Chief Executive Officer | -- | Direct | -- | Jan 13, 2022 |
Related Tickers
ARDX Ardelyx, Inc.
6.32
-1.79%
ADAP Adaptimmune Therapeutics plc
1.0879
+0.74%
KPTI Karyopharm Therapeutics Inc.
1.0400
-4.59%
MREO Mereo BioPharma Group plc
2.7600
-0.72%
GTHX G1 Therapeutics, Inc.
3.8350
-3.88%
DAWN Day One Biopharmaceuticals, Inc.
13.47
-11.36%
ABEO Abeona Therapeutics Inc.
3.1400
-0.95%
MCRB Seres Therapeutics, Inc.
0.7644
+4.78%
XFOR X4 Pharmaceuticals, Inc.
1.2200
-5.43%
OCUL Ocular Therapeutix, Inc.
4.2600
-8.29%